Three innovators working to change cancer care awarded a combined $100,000 in grants following live pitch to a panel of judges that included celebrity entrepreneur Bill Rancic

Astellas ranked in recognition of its commitment and support for working mothers

Astellas recognized by Great Place to Work® Institute

Results from the PROSPER trial show a median metastasis-free survival (MFS) of 36.6 months for enzalutamide plus androgen deprivation therapy (ADT) vs 14.7 months for men who received placebo plus ADT(1)

Bill and Giuliana Rancic to Lend Expertise, Passion and Personal Cancer Experience to Inspire Fellow Entrepreneurs

--Additional marketing award received for Best Video/TV Campaign--

Winner Will Attend Live Taping of ABC's "Dancing with the Stars"